Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc. (SION) Stock Overview

Explore Sionna Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SION●NASDAQ
HealthcareBiotechnology
$45.38
$0.32(0.70%)
U.S. Market opens in 15h 20m

Sionna Therapeutics, Inc. (SION)

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio-23.67
EPS (TTM)$-1.93
ROE-0.27%
Fundamental Analysis

AI Price Forecasts

1 Month$43.77
3 Months$55.53
1 Year Target$67.14

SION Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Sionna Therapeutics, Inc. (NASDAQ: SION) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Sionna Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SION on the NASDAQ shows an RSI of 53.94, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $67.14 for the NASDAQ listing.

Key metrics behind Sionna Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -23.67 and a market capitalization of 2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SION on the NASDAQ.

Price Performance (NASDAQ: SION)

1-Day Change
-0.70%
5-Day Change
-3.28%
1-Month Change
7.59%
3-Month Change
15.74%
6-Month Change
4.56%
Year-to-Date (YTD) Change
10.31%
1-Year Change
128.61%
3-Year Change
81.52%
5-Year Change
81.52%
All-Time (Max) Change
81.52%

Contact Information

https://www.sionnatx.com
617 819 2020
21 Hickory Drive Suite 500, Waltham, MA, 02451

Company Facts

590 Employees
IPO DateFeb 7, 2025
CountryUS
Actively Trading

Frequently Asked Questions